| Name | Title | Contact Details |
|---|
Our mission at Aveda is to care for the world we live in, from the products we make to the ways in which we give back to society.
Bodyport is the platform for health in the home. Understand your body on a deeper level. Predict and prevent disease.
KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.
TRIMEDX is a technology-enabled, clinical asset management company, anchored on a strong foundation of clinical engineering, exclusively serving the healthcare community. As the largest independent technology-enabled clinical asset management company in the U.S., TRIMEDX provides strategic planning for - and management of - clinical assets to drive reductions in operational expenses, free up capital for new strategic initiatives, and deliver improved safety and cyber protection. Headquartered in Indianapolis, Indiana, TRIMEDX was built by providers, for providers, and leverages a history of expert clinical engineering to manage over $30 billion in clinical assets across thousands of locations. Our programs include flexible, yet comprehensive management of all patient-based technology, including biomedical, imaging, laboratory, and specialty equipment. Key features of our programs include: • Client Experience Center • Parts and Service Procurement Center • Regulatory Compliance Team • Computerized Maintenance Management System • Equipment Lifecycle Management In September of 2012, TRIMEDX was recognized by Modern Healthcare Magazine as the #1 Clinical Equipment Maintenance Contractor.
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway.